Merck, 1004921000, Oxalic acid dihydrate

Application

In Situ Investigation of a Self-Accelerated Cocrystal Formation by Grinding Pyrazinamide with Oxalic Acid.: This study investigates the in situ cocrystal formation of pyrazinamide and oxalic acid dihydrate, emphasizing the self-accelerating nature of the process and its implications for pharmaceutical development (Kulla et al., 2016).

Deuterium MAS NMR studies of dynamics on multiple timescales: histidine and oxalic acid.: This article examines the dynamics of oxalic acid dihydrate and histidine using deuterium magnetic angle spinning nuclear magnetic resonance, providing insights into molecular motions on various timescales (Chan-Huot et al., 2015).

Analysis Note
Assay (manganometric): ≥ 99.0 %
Chloride (Cl): ≤ 0.002 %
Sulfate (SO₄): ≤ 0.02 %
Heavy metals (as Pb): ≤ 0.002 %
Total nitrogen (N): ≤ 0.005 %
Fe (Iron): ≤ 0.001 %
Residue on ignition (800 °C as sulfate): ≤ 0.05 %
Legal Information
EMPLURA is a registered trademark of Merck KGaA, Darmstadt, Germany